Ensign Peak Advisors’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.97M Sell
84,679
-599,942
-88% -$18.7M ﹤0.01% 713
2025
Q4
$30.3M Sell
684,621
-55,809
-8% -$3.13M 0.05% 243
2025
Q3
$54.2M Buy
740,430
+44,761
+6% +$2.92M 0.09% 187
2025
Q2
$42.7M Buy
695,669
+510,169
+275% +$28.5M 0.07% 216
2025
Q1
$10.8M Sell
185,500
-112,215
-38% -$7.09M 0.02% 444
2024
Q4
$15.9M Sell
297,715
-28,975
-9% -$1.42M 0.03% 358
2024
Q3
$14.2M Hold
326,690
0.03% 386
2024
Q2
$9.14M Buy
326,690
+294,132
+903% +$7.76M 0.02% 464
2024
Q1
$876K Sell
32,558
-1,642
-5% -$46.8K ﹤0.01% 1409
2023
Q4
$959K Buy
34,200
+2,800
+9% +$66.1K ﹤0.01% 1408
2023
Q3
$666K Hold
31,400
﹤0.01% 1469
2023
Q2
$1.07M Sell
31,400
-24,069
-43% -$801K ﹤0.01% 1205
2023
Q1
$1.8M Buy
55,469
+4,342
+8% +$144K ﹤0.01% 887
2022
Q4
$1.72M Buy
51,127
+29,100
+132% +$889K ﹤0.01% 869
2022
Q3
$666K Buy
+22,027
New +$807K ﹤0.01% 1304

Other funds holding DOCS

Ensign Peak Advisors's DOCS Position: Q1 2026 in Review

Ensign Peak Advisors reduced its Doximity (DOCS) stake by 88% in Q1 2026, selling an estimated $18.7M and leaving 84,679 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #713.

Ensign Peak Advisors first reported a position in DOCS in Q3 2022 and has held it in 15 quarters since. The position peaked at $54.2M in Q3 2025. 419 funds tracked by Wall St. Rank hold DOCS as of Q1 2026.

  • Ensign Peak Advisors held 84,679 shares of Doximity worth $1.97M as of Q1 2026.
  • Ensign Peak Advisors sold 599,942 Doximity shares in Q1 2026, an estimated $18.7M.
  • Doximity made up ﹤0.01% of Ensign Peak Advisors's portfolio in Q1 2026, its #713 holding.
  • Ensign Peak Advisors first reported a position in Doximity in Q3 2022 and has held it in 15 quarters since.
  • Ensign Peak Advisors's Doximity position peaked at $54.2M in Q3 2025.
  • 419 funds tracked by Wall St. Rank held Doximity as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.